Fosun agrees to buy KKR-backed Indian drug maker for $1.4 bln -source
July 27, 2016 at 23:18 PM EDT
HONG KONG, July 28 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy Gland Pharma - which is backed by KKR & Co LP - for about $1.4 billion, a person with direct knowledge of the matter said, in India's largest inbound acquisition this year.
